Literature DB >> 28800965

The CRISPR/Cas9-facilitated multiplex pathway optimization (CFPO) technique and its application to improve the Escherichia coli xylose utilization pathway.

Xinna Zhu1, Dongdong Zhao1, Huanna Qiu2, Feiyu Fan1, Shuli Man3, Changhao Bi4, Xueli Zhang5.   

Abstract

One of the most important research subjects of metabolic engineering is the pursuit of balanced metabolic pathways, which requires the modulation of expression of many genes. However, simultaneously modulating multiple genes on the chromosome remains challenging in prokaryotic organisms, including the industrial workhorse - Escherichia coli. In this work, the CRISPR/Cas9-facilitated multiplex pathway optimization (CFPO) technique was developed to simultaneously modulate the expression of multiple genes on the chromosome. To implement it, two plasmids were employed to target Cas9 to regulatory sequences of pathway genes, and a donor DNA plasmid library was constructed containing a regulator pool to modulate the expression of these genes. A modularized plasmid construction strategy was used to enable the assembly of a complex donor DNA plasmid library. After genome editing using this technique, a combinatorial library was obtained with variably expressed pathway genes. As a demonstration, the CFPO technique was applied to the xylose metabolic pathway genes in E. coli to improve xylose utilization. Three transcriptional units containing a total of four genes were modulated simultaneously with 70% efficiency, and improved strains were selected from the resulting combinatorial library by growth enrichment. The best strain, HQ304, displayed a 3-fold increase of the xylose-utilization rate. Finally, the xylose-utilization pathway of HQ304 was analyzed enzymologically to determine the optimal combination of enzyme activities.
Copyright © 2017 International Metabolic Engineering Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRISPR/Cas9; CRISPR/Cas9-facilitated multiplex pathway optimization (CFPO); Combinatorial metabolic engineering; Genome editing

Mesh:

Substances:

Year:  2017        PMID: 28800965     DOI: 10.1016/j.ymben.2017.08.003

Source DB:  PubMed          Journal:  Metab Eng        ISSN: 1096-7176            Impact factor:   9.783


  11 in total

Review 1.  Advancing biotechnology with CRISPR/Cas9: recent applications and patent landscape.

Authors:  Raphael Ferreira; Florian David; Jens Nielsen
Journal:  J Ind Microbiol Biotechnol       Date:  2018-01-24       Impact factor: 3.346

2.  Reconstitution of TCA cycle involving l-isoleucine dioxygenase for hydroxylation of l-isoleucine in Escherichia coli using CRISPR-Cas9.

Authors:  Jianhong An; Wenli Zhang; Xiaoran Jing; Yao Nie; Yan Xu
Journal:  3 Biotech       Date:  2020-03-13       Impact factor: 2.406

3.  xylA and xylB overexpression as a successful strategy for improving xylose utilization and poly-3-hydroxybutyrate production in Burkholderia sacchari.

Authors:  Linda P Guamán; Edmar R Oliveira-Filho; Carlos Barba-Ostria; José G C Gomez; Marilda K Taciro; Luiziana Ferreira da Silva
Journal:  J Ind Microbiol Biotechnol       Date:  2018-01-19       Impact factor: 3.346

Review 4.  Applications of CRISPR/Cas System to Bacterial Metabolic Engineering.

Authors:  Suhyung Cho; Jongoh Shin; Byung-Kwan Cho
Journal:  Int J Mol Sci       Date:  2018-04-05       Impact factor: 5.923

5.  CRISPR/Cas9-facilitated engineering with growth-coupled and sensor-guided in vivo screening of enzyme variants for a more efficient chorismate pathway in E. coli.

Authors:  Minliang Chen; Lin Chen; An-Ping Zeng
Journal:  Metab Eng Commun       Date:  2019-05-06

6.  Development and characterization of a CRISPR/Cas9n-based multiplex genome editing system for Bacillus subtilis.

Authors:  Dingyu Liu; Can Huang; Jiaxin Guo; Peiji Zhang; Tao Chen; Zhiwen Wang; Xueming Zhao
Journal:  Biotechnol Biofuels       Date:  2019-09-27       Impact factor: 6.040

7.  Combinatorial modulation of initial codons for improved zeaxanthin synthetic pathway efficiency in Escherichia coli.

Authors:  Zaiqiang Wu; Dongdong Zhao; Siwei Li; Junsong Wang; Changhao Bi; Xueli Zhang
Journal:  Microbiologyopen       Date:  2019-09-18       Impact factor: 3.139

8.  In-situ generation of large numbers of genetic combinations for metabolic reprogramming via CRISPR-guided base editing.

Authors:  Yu Wang; Haijiao Cheng; Yang Liu; Ye Liu; Xiao Wen; Kun Zhang; Xiaomeng Ni; Ning Gao; Liwen Fan; Zhihui Zhang; Jiao Liu; Jiuzhou Chen; Lixian Wang; Yanmei Guo; Ping Zheng; Meng Wang; Jibin Sun; Yanhe Ma
Journal:  Nat Commun       Date:  2021-01-29       Impact factor: 14.919

9.  Integrated laboratory evolution and rational engineering of GalP/Glk-dependent Escherichia coli for higher yield and productivity of L-tryptophan biosynthesis.

Authors:  Chen Minliang; Ma Chengwei; Chen Lin; An-Ping Zeng
Journal:  Metab Eng Commun       Date:  2021-02-13

10.  CRISPR/Cas9 recombineering-mediated deep mutational scanning of essential genes in Escherichia coli.

Authors:  Jacob A Fenster; Reilly G Fankhauser; Olivier Tenaillon; Ryan T Gill; Alaksh Choudhury; Joel L Kaar
Journal:  Mol Syst Biol       Date:  2020-03       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.